Abstract |
A series of monomeric and dimeric naphthoquinones with potential for treatment of Leishmania infections was identified in vitro using both a direct cytotoxicity assay against extracellular promastigotes of Leishmania donovani, Leishmania infanturn, Leishmania enriettii, and Leishmania major and a test against intracellular amastigote L. donovani residing within murine macrophages. Several naphthoquinones proved to be active at concentrations in the microgram range (EC(50) 0.9-17.0 microg/ml). When tested against a panel of human cancer cell lines (KB, SKMel, A549, MDA) and murine bone marrow culture-derived macrophages (BMMPhi) as mammalian host cell controls, compounds with anti-Leishmania-activity showed moderate (EC(50)>25 microg/ml) to pronounced (EC(50)<10 microg/ml) toxic effects.
|
Authors | O Kayser, A F Kiderlen, H Laatsch, S L Croft |
Journal | Acta tropica
(Acta Trop)
Vol. 76
Issue 2
Pg. 131-8
(Sep 18 2000)
ISSN: 0001-706X [Print] Netherlands |
PMID | 10936572
(Publication Type: Comparative Study, Journal Article)
|
Chemical References |
|
Topics |
- Animals
- Humans
- Leishmania
(drug effects)
- Leishmania donovani
(drug effects)
- Leishmania enriettii
(drug effects)
- Leishmania infantum
(drug effects)
- Leishmania major
(drug effects)
- Leishmaniasis
(drug therapy)
- Macrophages
(drug effects, parasitology)
- Naphthoquinones
(pharmacology)
- Tumor Cells, Cultured
(drug effects, parasitology)
|